Cargando…

Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages

BACKGROUND: The effect of progesterone elevation (PE) on the day of human chorionic gonadotropin (hCG) administration on the pregnancy outcomes of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles is a matter of ongoing debate. The replacement of cleavage-stage embryos with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yan, Wang, En-yin, Du, Qing-yun, Xiong, Yu-jing, Guo, Xiao-yi, Yu, Yi-ping, Sun, Ying-pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524365/
https://www.ncbi.nlm.nih.gov/pubmed/26238449
http://dx.doi.org/10.1186/s12958-015-0075-3
_version_ 1782384180218298368
author Huang, Yan
Wang, En-yin
Du, Qing-yun
Xiong, Yu-jing
Guo, Xiao-yi
Yu, Yi-ping
Sun, Ying-pu
author_facet Huang, Yan
Wang, En-yin
Du, Qing-yun
Xiong, Yu-jing
Guo, Xiao-yi
Yu, Yi-ping
Sun, Ying-pu
author_sort Huang, Yan
collection PubMed
description BACKGROUND: The effect of progesterone elevation (PE) on the day of human chorionic gonadotropin (hCG) administration on the pregnancy outcomes of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles is a matter of ongoing debate. The replacement of cleavage-stage embryos with blastocyst-stage embryos for transfer was proposed to avoid the possible impairment of PE in fresh cycles. This study aimed to assess the association between PE on the day of human chorionic gonadotropin (hCG) administration and clinical pregnancy rates (CPRs) in IVF/ICSI cycles with embryos transferred at different developmental stages (cleavage and blastocyst). Moreover, a secondary aim was to determine the thresholds at which PE has a detrimental effect on CPRs. METHODS: This single-center retrospective cohort study included more than 10,000 patients undergoing day 3 cleavage-stage embryo transfer (ET) and 1146 patients undergoing day 5 blastocyst-stage embryo transfer (ET) using gonadotropin and GnRH agonist for controlled ovarian stimulation. RESULTS: Serum PE was inversely associated with CPRs in both cleavage- and blastocyst-stage ET cycles. In the day 3 ET cycles, CPRs (progesterone levels < 0.5 ng/ml, 49.2 %) significantly declined when the progesterone concentration reached 1.0 ng/ml (45.5 %) and decreased further when the progesterone concentration increased to 1.5 ng/ml (36.2 %). In the day 5 blastocyst-stage ET cycles, patients with serum progesterone levels ≥1.75 ng/ml had significantly lower CPRs (31.3 % VS. 41.4 %, p < 0.001) compared to patients with serum progesterone levels <1.75 ng/ml. The negative association of PE with CPRs was noted in both ET groups, even after adjusting for confounders. Furthermore, the developmental stage of the transferred embryos was not linked to the effect of PE on CPRs because the interaction between the developmental stage of the transferred embryos and PE was not significant. CONCLUSIONS: PE on the day of hCG administration is associated with decreased CPRs in GnRH agonist IVF/intracytoplasmic sperm injection (ICSI) cycles regardless of the developmental stage of the transferred embryos (cleavage versus blastocyst stage).
format Online
Article
Text
id pubmed-4524365
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45243652015-08-05 Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages Huang, Yan Wang, En-yin Du, Qing-yun Xiong, Yu-jing Guo, Xiao-yi Yu, Yi-ping Sun, Ying-pu Reprod Biol Endocrinol Research BACKGROUND: The effect of progesterone elevation (PE) on the day of human chorionic gonadotropin (hCG) administration on the pregnancy outcomes of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles is a matter of ongoing debate. The replacement of cleavage-stage embryos with blastocyst-stage embryos for transfer was proposed to avoid the possible impairment of PE in fresh cycles. This study aimed to assess the association between PE on the day of human chorionic gonadotropin (hCG) administration and clinical pregnancy rates (CPRs) in IVF/ICSI cycles with embryos transferred at different developmental stages (cleavage and blastocyst). Moreover, a secondary aim was to determine the thresholds at which PE has a detrimental effect on CPRs. METHODS: This single-center retrospective cohort study included more than 10,000 patients undergoing day 3 cleavage-stage embryo transfer (ET) and 1146 patients undergoing day 5 blastocyst-stage embryo transfer (ET) using gonadotropin and GnRH agonist for controlled ovarian stimulation. RESULTS: Serum PE was inversely associated with CPRs in both cleavage- and blastocyst-stage ET cycles. In the day 3 ET cycles, CPRs (progesterone levels < 0.5 ng/ml, 49.2 %) significantly declined when the progesterone concentration reached 1.0 ng/ml (45.5 %) and decreased further when the progesterone concentration increased to 1.5 ng/ml (36.2 %). In the day 5 blastocyst-stage ET cycles, patients with serum progesterone levels ≥1.75 ng/ml had significantly lower CPRs (31.3 % VS. 41.4 %, p < 0.001) compared to patients with serum progesterone levels <1.75 ng/ml. The negative association of PE with CPRs was noted in both ET groups, even after adjusting for confounders. Furthermore, the developmental stage of the transferred embryos was not linked to the effect of PE on CPRs because the interaction between the developmental stage of the transferred embryos and PE was not significant. CONCLUSIONS: PE on the day of hCG administration is associated with decreased CPRs in GnRH agonist IVF/intracytoplasmic sperm injection (ICSI) cycles regardless of the developmental stage of the transferred embryos (cleavage versus blastocyst stage). BioMed Central 2015-08-04 /pmc/articles/PMC4524365/ /pubmed/26238449 http://dx.doi.org/10.1186/s12958-015-0075-3 Text en © Huang et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Huang, Yan
Wang, En-yin
Du, Qing-yun
Xiong, Yu-jing
Guo, Xiao-yi
Yu, Yi-ping
Sun, Ying-pu
Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title_full Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title_fullStr Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title_full_unstemmed Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title_short Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
title_sort progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of ivf with transferred embryos at different developmental stages
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524365/
https://www.ncbi.nlm.nih.gov/pubmed/26238449
http://dx.doi.org/10.1186/s12958-015-0075-3
work_keys_str_mv AT huangyan progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT wangenyin progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT duqingyun progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT xiongyujing progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT guoxiaoyi progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT yuyiping progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages
AT sunyingpu progesteroneelevationonthedayofhumanchorionicgonadotropinadministrationadverselyaffectstheoutcomeofivfwithtransferredembryosatdifferentdevelopmentalstages